You can help expand this article with text translated from the corresponding article in Czech. (January 2026) Click [show] for important translation instructions.
View a machine-translated version of the Czech article.
Machine translation, like DeepL or Google Translate, is a useful starting point for translations, but translators must follow the LLM translation guideline, revise errors as necessary and confirm that the translation is accurate, rather than simply copy-pasting machine-translated text into the English Wikipedia.
Do not translate text that appears unreliable or low-quality. If possible, verify the text with references provided in the foreign-language article.
You must provide copyright attribution in the edit summary accompanying your translation by providing an interlanguage link to the source of your translation. A model attribution edit summary is Content in this edit is translated from the existing Czech Wikipedia article at [[:cs:Kauza Diag Human]]; see its history for attribution.
You may also add the template {{Translated|cs|Kauza Diag Human}} to the talk page.
This article needs to be updated. Please help update this article to reflect recent events or newly available information.(January 2026)
The Diag Human case relates to a Liechtenstein-incorporated blood plasma trading company, established by Swiss-Czech entrepreneur Josef Šťáva (born 17 March 1950 in Prague) in the 1980s.[1] The stated aim of the company was to help "currency-deficient Eastern Bloc states acquire modern blood plasma technology".[1] The company received media attention in the 1996, when it filed a lawsuit against the Czech government in Prague Commercial Court, for defamation and unfair competition. The company claimed that the Health Minister had contacted Novo Nordisk, a major business partner of Diag Human, to dissuade the company from doing business with them, which led to the failure of Diag Human's business in the country.[1] The two parties agreed to enter arbitration,[1] and the case became one of the largest cases of commercial litigation in the history of Czech Republic.[2] In 2008, the court found in favour of Diag Human, awarding around $650 million to the company.[1]
